Nov 20 (Reuters) – Natco Pharma Ltd: * NATCO PHARMA – RECEIVES EIR FROM U.S. FDA FOR FDF UNIT * NATCO PHARMA – COMPANY RECEIVED 4 OBSERVATIONS IN FORM-483 AT FDA INSPECTION CONCLUSION * NATCO PHARMA –
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
* Gold eyes biggest weekly fall since March * Silver, platinum and palladium head for…
By Jiaxing Li and Rae Wee HONG KONG/SINGAPORE, Nov 20 (Reuters) - Asian shares fell…
By Alexandra Alper WASHINGTON, Nov 18 (Reuters) - The Trump administration is considering requiring US…
Jimmy Snuggerud scored twice and Dylan Holloway put in the tie-breaking goal for the visiting…
By Tatiana Bautzer and Elisa Martinuzzi NEW YORK/LONDON, Nov 19 (Reuters) - Citigroup underestimated its…
SYDNEY, Nov 20 (Reuters) - A data centre planned in regional Australia with Anthropic as…